Premium Membership - Holiday Season Special - 75% off

investorscraft@gmail.com

Investor's Craft

Stock Screeners
Stock Indices
Stock Valuation

Intrinsic Value of Vertex Pharmaceuticals Incorporated (VRTX)

Previous Close$465.70
Intrinsic Value$190.03
Upside potential  -59%
Previous Close
$465.70
Intrinsic Value
$190.03
Potential        
-59%

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

Intrinsic Value Stock Screener
Artificial intelligence value of

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %17.9NaN
Revenue, $8931NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m4623NaN
Operating income, $m4307NaN
EBITDA, $m4456NaN
Interest expense (income), $mNaN
Earnings before tax, $m4232NaN
Tax expense, $m910NaN
Net income, $m3322NaN

BALANCE SHEET

Cash and short-term investments, $m10779NaN
Total assets, $m18151NaN
Adjusted assets (=assets-cash), $m7372NaN
Average production assets, $m2648NaN
Working capital, $m10493NaN
Total debt, $m520NaN
Total liabilities, $m4238NaN
Total equity, $m13913NaN
Debt-to-equity ratio0.037NaN
Adjusted equity ratio0.437NaN

CASH FLOW

Net income, $m3322NaN
Depreciation, amort., depletion, $m148NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m4130NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-205NaN
Free cash flow, $m4335NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m10493
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount